MML Investors Services’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
PA
EA
EMFAT
BTW
FWP
MML Investors Services's CORT Position: Q2 2026 in Review
MML Investors Services increased its Corcept Therapeutics (CORT) stake by 76% in Q2 2026, buying an estimated $579K and bringing the position to 22,264 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1555.
MML Investors Services first reported a position in CORT in Q1 2018 and has held it in 14 quarters since. 188 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- MML Investors Services held 22,264 shares of Corcept Therapeutics worth $1.94M as of Q2 2026.
- MML Investors Services bought 9,592 Corcept Therapeutics shares in Q2 2026, an estimated $579K.
- Corcept Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1555 holding.
- MML Investors Services first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 14 quarters since.
- 188 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.